PATH transforms diagnostic technologies to promote optimal health outcomes in low-resource settings. We make high-impact, affordable diagnostic tools available, accessible, and adoptable.
Low-cost, simple, point-of-care blood tests for G6PD enzyme deficiency are a key part of Plasmodium vivax malaria treatment, and a step towards eliminating malaria overall
New rapid point of care diagnostic tests for malaria can identify patients who have few symptoms, but carry the malaria parasite nonetheless
A new multiplexed immunoassay enables simultaneous, cost-effective population surveillance for micronutrient deficiencies and health conditions using just a drop of blood
New rapid diagnostic tests for onchocerciasis (river blindness) and lymphatic filariasis will guide surveillance of mass drug administration programs needed for elimination.
The world has changed in remarkable—even unprecedented—ways since PATH got its start. Now we're accelerating our efforts to create greater health, equity, and opportunity everywhere.
One of the world’s deadliest diseases may be eliminated through new tools and a commitment from the Democratic Republic of the Congo.
Subscribe to DxNEWS to receive periodic updates and information from the PATH Diagnostics program.
Browse resources and publications from our program in the PATH resource database.